MCRC: nomogram predicts early mortality on initial treatment

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Validated clinical nomogram has been developed that quantifies the risk for early death in patients during initial treatment of metastatic colorectal cancer (mCRC) and may be used for treatment stratification.

Why this matters

  • Prognostic factors associated with early mortality...